Spinal FrontiersPowered by NSpineWeekly alert sign-up
← Back

Spinal Frontiers · Regulatory Watch · FDA decision

SurGenTec clears lateral SI joint fusion system

FDA decision · SurGenTec

24 August 2026

SurGenTec's TiLink-L sacroiliac joint fusion system was cleared, with navigation listed as a secondary product code.

Type
FDA decision
Company
SurGenTec
Device
TiLink-L SI Joint Fusion System
Date
24 August 2026
Jurisdiction
US
Classification
510(k) K261381 (OUR; OLO)
Source
FDA 510(k) database

Official source →Source checked

More from Regulatory Watch on SurGenTec

Other FDA decisions

← All of Regulatory Watch

Spinal Frontiers is published by NSpine Limited, registered in England and Wales (company no. 08362634), 14 Park Row, Nottingham NG1 6GR, United Kingdom. Every item is summarised in our own words and links to its original source. Listings are a selection made at NSpine's editorial discretion and are not exhaustive; inclusion is not an endorsement, and omission implies nothing. Sponsors and advertisers have no influence on what we cover. Nothing here is medical, legal or financial advice. Spotted an error or a broken link? Email spinalfrontiers@nspine.com, or use the feedback page.

Spinal Frontiers is a trademark of NSpine GmbH.

Information only, summarised from third-party sources: not medical, legal, regulatory or financial advice. Full disclaimer.

© 2013 – 2026 NSpine Limited. Privacy notice.